TERN
Terns Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$52.95
−0.03%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-9.6%
Return on equity
-9.4%
Return on assets
-10.9%
Return on invested capital
0.00x
Asset turnover
-$82.2M
Cash from operations
$8.82
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025